{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:36:31Z","timestamp":1794850591322,"version":"4.9.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006928","name":"The Ohio State University","doi-asserted-by":"publisher","award":["PG100125"],"award-info":[{"award-number":["PG100125"]}],"id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI148180"],"award-info":[{"award-number":["R01AI148180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI187330"],"award-info":[{"award-number":["R01AI187330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cytogfr.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:42:00Z","timestamp":1761673320000},"page":"167-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["SARS-CoV-2 innate immune recognition and implications for respiratory health"],"prefix":"10.1016","volume":"86","author":[{"given":"Vandana","family":"Anang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamaluddin","family":"Pracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly","family":"Gowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Bednash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2323-1245","authenticated-orcid":false,"given":"Sourabh","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes A.","family":"Mebratu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41392-023-01640-z","article-title":"The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib3","unstructured":"W.H. Organization\", COVID-19 - Global Situation, 2025."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2023.105405","article-title":"Global SARS-CoV-2 genomic surveillance: what we have learned (so far)","volume":"108","author":"Tosta","year":"2023","journal-title":"Infect. Genet Evol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14070711","article-title":"Long COVID: long-term impact of SARS-CoV2","volume":"14","author":"Makhluf","year":"2024","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001424","article-title":"Manipulation of ACE2 expression in COVID-19","volume":"7","author":"Chaudhry","year":"2020","journal-title":"Open Heart"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib7","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260682","article-title":"Viral evasion of the interferon response at a glance","volume":"136","author":"Zhu","year":"2023","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.008_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.714","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bsheal.2023.08.005","article-title":"Role of innate immunity in SARS-CoV-2 infection","volume":"5","author":"Wang","year":"2023","journal-title":"Biosaf. Health"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.immuni.2024.03.012","article-title":"The NLR family of innate immune and cell death sensors","volume":"57","author":"Sundaram","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bjorkstrom","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.26502\/acbr.50170279","article-title":"Translational and clinical significance of DAMPs, PAMPs, and PRRs in trauma-induced Inflammation","volume":"6","author":"Rai","year":"2022","journal-title":"Arch. Clin. Biomed. Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098065","article-title":"TLRs: innate immune sentries against SARS-CoV-2 infection","volume":"24","author":"Mantovani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.10.008_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512464","article-title":"An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes","volume":"24","author":"Colleselli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/rmv.680","article-title":"Antiviral responses induced by the TLR3 pathway","volume":"21","author":"Matsumoto","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib22","first-page":"1","article-title":"Q. Yang, H.B. Shu, Deciphering the pathways to antiviral innate immunity and inflammation","volume":"145","year":"2020","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-025-00739-5","article-title":"Toll-like receptor 3: a double-edged sword","volume":"13","author":"Hsieh","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib24","doi-asserted-by":"crossref","first-page":"34278","DOI":"10.1038\/srep34278","article-title":"TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury","volume":"7","author":"Ding","year":"2017","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.008_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131195","article-title":"TLR3 absence confers increased survival with improved macrophage activity against pneumonia","volume":"4","author":"Suresh","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.008_bib26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib29","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/jmv.26589","article-title":"Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome","volume":"93","author":"Kerget","year":"2021","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humimm.2021.05.001","article-title":"Chemotherapy vs. immunotherapy in combating nCOVID19: an update","volume":"82","author":"Choudhury","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cytogfr.2024.10.001","article-title":"The Yin and Yang of TLR4 in COVID-19","volume":"82","author":"Mukherjee","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10565-021-09693-y","article-title":"SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders","volume":"38","author":"Cinquegrani","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-01753-z","article-title":"SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl(-) concentration","volume":"9","author":"Xu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107262","article-title":"Convalescent plasma may be a possible treatment for COVID-19: a systematic review","volume":"91","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110102","article-title":"SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression","volume":"143","author":"Cecchini","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib37","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in Inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol."},{"issue":"5663","key":"10.1016\/j.cytogfr.2025.10.008_bib38","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.008_bib39","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.1117359109","article-title":"Plasmacytoid dendritic cells control T-cell response to chronic viral infection","volume":"109","author":"Cervantes-Barragan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"605","key":"10.1016\/j.cytogfr.2025.10.008_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw1347","article-title":"TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection","volume":"12","author":"de Marcken","year":"2019","journal-title":"Sci. Signal"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198962","article-title":"SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19","volume":"323","author":"Aktar","year":"2023","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines","volume":"6","author":"Sartorius","year":"2021","journal-title":"NPJ Vaccin."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.immuni.2007.08.012","article-title":"Innate recognition of viruses","volume":"27","author":"Pichlmair","year":"2007","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of Genetic Variants Among Young Men With Severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"issue":"6515","key":"10.1016\/j.cytogfr.2025.10.008_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2023.02.003","article-title":"Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children","volume":"151","author":"Bucciol","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6504","key":"10.1016\/j.cytogfr.2025.10.008_bib47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111794","article-title":"Role of toll-like receptor 7\/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options","volume":"141","author":"Dyavar","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.10.008_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158285","article-title":"Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections","volume":"23","author":"Li","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41421-020-00208-3","article-title":"SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2","volume":"6","author":"Mu","year":"2020","journal-title":"Cell Discov."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13121117","article-title":"Strategies used by SARS-CoV-2 to evade the innate immune system in an evolutionary perspective","volume":"13","author":"Fan","year":"2024","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.008_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116083","article-title":"Newly emerged antiviral strategies for SARS-CoV-2: from deciphering viral protein structural function to the development of vaccines, antibodies, and small molecules","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.008_bib54","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.220259","article-title":"Antimelanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines","volume":"49","author":"Kitajima","year":"2022","journal-title":"J. Rheuma"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.008_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011792","article-title":"SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination","volume":"19","author":"Zhang","year":"2023","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92940-3","article-title":"The RNA sensor MDA5 detects SARS-CoV-2 infection","volume":"11","author":"Sampaio","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib57","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20081210","article-title":"Jr., Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity","volume":"205","author":"Saito","year":"2008","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-023-00259-5","article-title":"Innate immune recognition against SARS-CoV-2","volume":"43","author":"Yamada","year":"2023","journal-title":"Inflamm. Regen."},{"issue":"16","key":"10.1016\/j.cytogfr.2025.10.008_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022643118","article-title":"SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes","volume":"118","author":"Li","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01843-22","article-title":"LGP2 Promotes type i interferon production To Inhibit PRRSV infection via enhancing MDA5-mediated signaling","volume":"97","author":"Zhu","year":"2023","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","article-title":"The cGAS-STING defense pathway and Its counteraction by viruses","volume":"19","author":"Ma","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib62","doi-asserted-by":"crossref","first-page":"1006395","DOI":"10.3389\/fimmu.2022.1006395","article-title":"Involvement of the STING signaling in COVID-19","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41392-021-00800-3","article-title":"Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s42003-021-02983-5","article-title":"SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB","volume":"5","author":"Neufeldt","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108395","article-title":"Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis","volume":"788","author":"Kirsch-Volders","year":"2021","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"7899","key":"10.1016\/j.cytogfr.2025.10.008_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.2237","article-title":"Regulation of inflammasome signaling","volume":"13","author":"Rathinam","year":"2012","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib70","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2020.10.005","article-title":"Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques","volume":"183","author":"Aid","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2024.12.003","article-title":"The immunopathogenesis of a cytokine storm: the key mechanisms underlying severe COVID-19","volume":"82","author":"Hiti","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib74","doi-asserted-by":"crossref","first-page":"14209","DOI":"10.1038\/s41598-025-98505-y","article-title":"Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes","volume":"15","author":"Ghaffarpour","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28751","article-title":"The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection","volume":"95","author":"Qudus","year":"2023","journal-title":"J. Med Virol."},{"issue":"21","key":"10.1016\/j.cytogfr.2025.10.008_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202012119","article-title":"Caspase-4\/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis","volume":"119","author":"Eltobgy","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib77","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nri.2016.55","article-title":"C-type lectin receptors in the control of T helper cell differentiation","volume":"16","author":"Geijtenbeek","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib78","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri2569","article-title":"Signalling through C-type lectin receptors: shaping immune responses","volume":"9","author":"Geijtenbeek","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/biology10010001","article-title":"C-type Lectin CD209L\/L-SIGN and CD209\/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors","volume":"10","author":"Rahimi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib80","doi-asserted-by":"crossref","unstructured":"R. Amraei, W. Yin, M.A. Napoleon, E.L. Suder, J. Berrigan, Q. Zhao, J. Olejnik, K.B. Chandler, C. Xia, J. Feldman, B.M. Hauser, T.M. Caradonna, A.G. Schmidt, S. Gummuluru, E. Muhlberger, V. Chitalia, C.E. Costello, N. Rahimi, CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2, bioRxiv (2021).","DOI":"10.1101\/2020.06.22.165803"},{"issue":"7816","key":"10.1016\/j.cytogfr.2025.10.008_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.008_bib82","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell Mol. Immunol."},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.008_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317078","article-title":"Ligand Recognition by the macrophage galactose-type C-type lectin: self or non-self?-A way to trick the host's immune system","volume":"24","author":"Szczykutowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102521","article-title":"Myeloid C-type lectin receptors in host-pathogen interactions and glycan-based targeting","volume":"82","author":"Stegmann","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib85","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1038\/s44319-024-00296-2","article-title":"The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity","volume":"25","author":"Malamud","year":"2024","journal-title":"EMBO Rep."},{"issue":"32","key":"10.1016\/j.cytogfr.2025.10.008_bib86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants","volume":"119","author":"Guo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/v17040528","article-title":"Chasing Virus Replication and Infection: PAMP-PRR interaction drives type i interferon production, which in turn activates ISG expression and ISGylation","volume":"17","author":"Muhammad","year":"2025","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.008_bib88","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41564-020-0769-y","article-title":"LY6E impairs coronavirus fusion and confers immune control of viral disease","volume":"5","author":"Pfaender","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"18","key":"10.1016\/j.cytogfr.2025.10.008_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00562-20","article-title":"LY6E Restricts entry of human coronaviruses, including currently pandemic SARS-CoV-2","volume":"94","author":"Zhao","year":"2020","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.008_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009820","article-title":"TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction","volume":"17","author":"Khan","year":"2021","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib91","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41564-018-0273-9","article-title":"The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry","volume":"3","author":"Doyle","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"6513","key":"10.1016\/j.cytogfr.2025.10.008_bib92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1126\/science.abb3753","article-title":"MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses","volume":"370","author":"Bruchez","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.008_bib93","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15252\/embr.201744100","article-title":"IFITM3 requires an amphipathic helix for antiviral activity","volume":"18","author":"Chesarino","year":"2017","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.008_bib94","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41588-022-01131-x","article-title":"Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection","volume":"54","author":"Biering","year":"2022","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib95","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41467-022-30134-9","article-title":"Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR\/Cas9 screen","volume":"13","author":"Mac Kain","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01930-20","article-title":"SARS-CoV-2 Is restricted by zinc finger antiviral protein despite preadaptation to the Low-CpG environment in humans","volume":"11","author":"Nchioua","year":"2020","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib97","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/JVI.02406-09","article-title":"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases","volume":"84","author":"Clementz","year":"2010","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib98","first-page":"178","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib99","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.008_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01257-21","article-title":"The NF-kappaB transcriptional footprint Is essential for SARS-CoV-2 replication","volume":"95","author":"Nilsson-Payant","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib101","article-title":"SARS-CoV-2 spike antagonizes innate antiviral immunity by targeting interferon regulatory factor 3","volume":"11","author":"Freitas","year":"2021","journal-title":"Front Cell Infect. Microbiol."},{"issue":"24","key":"10.1016\/j.cytogfr.2025.10.008_bib102","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1074\/jbc.M109.008227","article-title":"Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1\/IKKepsilon complex","volume":"284","author":"Siu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662989","article-title":"SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1","volume":"12","author":"Sui","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13020164","article-title":"The Role of the Nuclear Factor-Kappa B (NF-kappaB) Pathway in SARS-CoV-2 Infection","volume":"13","author":"Kesika","year":"2024","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-00571-x","article-title":"SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response","volume":"18","author":"Fu","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.008_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/v13081439","article-title":"SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity","volume":"13","author":"Gori Savellini","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib107","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib108","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib109","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2020.10.004","article-title":"SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses","volume":"183","author":"Banerjee","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109126","article-title":"Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities","volume":"35","author":"Hayn","year":"2021","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib111","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02335-21","article-title":"SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS To evade the innate immune response","volume":"12","author":"Liu","year":"2021","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of Type I Interferon by SARS-CoV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib114","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","author":"Yuen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.008_bib115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","article-title":"The ORF3a protein of SARS-CoV-2 induces apoptosis in cells","volume":"17","author":"Ren","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant","volume":"32","author":"Konno","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708264","article-title":"SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns","volume":"12","author":"Redondo","year":"2021","journal-title":"Front Immunol."},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.008_bib118","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024202118","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib119","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00402-22","article-title":"Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8","volume":"13","author":"Wu","year":"2022","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib120","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","article-title":"SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70","volume":"17","author":"Jiang","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib121","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41423-021-00807-4","article-title":"SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy","volume":"19","author":"Li","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01604-22","article-title":"SARS-CoV-2 variant delta potently suppresses innate immune response and evades interferon-activated antiviral responses in human colon epithelial cells","volume":"10","author":"Tandel","year":"2022","journal-title":"Microbiol Spectr."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41564-023-01588-4","article-title":"Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants","volume":"9","author":"Reuschl","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib124","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104673","article-title":"The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options","volume":"150","author":"Choudhary","year":"2021","journal-title":"Micro Pathog."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The pro-inflammatory cytokines in COVID-19 pathogenesis: what goes wrong?","volume":"153","author":"Darif","year":"2021","journal-title":"Microb Pathog."},{"issue":"1-2","key":"10.1016\/j.cytogfr.2025.10.008_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","article-title":"COVID 19: a clue from innate immunity","volume":"68","author":"Birra","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109935","article-title":"IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19","volume":"144","author":"Leija-Martinez","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.008_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314959","article-title":"Pulmonary Fibrosis as a Result of Acute Lung Inflammation: molecular mechanisms, relevant In vivo models, prognostic and therapeutic approaches","volume":"23","author":"Savin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib132","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.2022.13072","article-title":"Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients","volume":"328","author":"Lo Re","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.008_bib133","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may Contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076142","article-title":"Prospective roles of tumor necrosis factor-alpha (TNF-alpha) in COVID-19: prognosis, therapeutic and management","volume":"24","author":"Mohd Zawawi","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib136","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.26350","article-title":"SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19","volume":"91","author":"Peluso","year":"2022","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/JLB.3MA0322-279RRR","article-title":"Loss of mitochondrial membrane potential (DeltaPsi(m)) in leucocytes as post-COVID-19 sequelae","volume":"112","author":"Diaz-Resendiz","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib138","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244628","article-title":"Interleukine-6 in critically ill COVID-19 patients: a retrospective analysis","volume":"15","author":"Gorham","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2007.04.009","article-title":"Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB","volume":"365","author":"Zhang","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40249-020-00646-x","article-title":"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review","volume":"9","author":"Adhikari","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib142","article-title":"Interleukin-8 as a biomarker for disease prognosis of coronavirus disease-2019 patients","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib143","article-title":"SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation","author":"Li","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib144","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12950-023-00329-y","article-title":"Neutrophil extracellular traps and pulmonary fibrosis: an update","volume":"20","author":"Yan","year":"2023","journal-title":"J. Inflamm."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061383","article-title":"Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19","volume":"9","author":"Tomar","year":"2020","journal-title":"Cells"},{"issue":"Pt B","key":"10.1016\/j.cytogfr.2025.10.008_bib146","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib147","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib148","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"15","key":"10.1016\/j.cytogfr.2025.10.008_bib149","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10030501","article-title":"Innate Immune Response in SARS-CoV-2 Infection","volume":"10","author":"Schiuma","year":"2022","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib152","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3349\/ymj.2021.62.5.381","article-title":"Roles of Type I and III Interferons in COVID-19","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib153","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.008_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092942","article-title":"Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy","volume":"9","author":"Thierry","year":"2020","journal-title":"J. Clin. Med"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/15548627.2022.2099206","article-title":"Neutrophil autophagy and NETosis in COVID-19: perspectives","volume":"19","author":"Zhang","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib156","first-page":"5566826","article-title":"Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury","author":"Obermayer","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cytogfr.2025.10.008_bib157","first-page":"17","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib158","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.008_bib159","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11427-010-0045-0","article-title":"Plasmacytoid dendritic cells in antiviral immunity and autoimmunity","volume":"53","author":"Tang","year":"2010","journal-title":"Sci. China Life Sci."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib160","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med"},{"issue":"6508","key":"10.1016\/j.cytogfr.2025.10.008_bib161","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib162","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the 'missing self': MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.008_bib163","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4049\/jimmunol.143.4.1210","article-title":"IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells","volume":"143","author":"Maraskovsky","year":"1989","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.008_bib164","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010064","article-title":"The latest approach of immunotherapy with endosomal TLR agonists improving NK cell function: an overview","volume":"11","author":"Veneziani","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.008_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01204-23","article-title":"Harnessing the power of IFN for therapeutic approaches to COVID-19","volume":"98","author":"Viox","year":"2024","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.008_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108761","article-title":"SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO","volume":"34","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib168","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40121-022-00633-9","article-title":"Interferon treatments for SARS-CoV-2: challenges and opportunities","volume":"11","author":"Jhuti","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.cytogfr.2025.10.008_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108517","article-title":"Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment","volume":"218","author":"Yeleswaram","year":"2020","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.008_bib170","first-page":"24","article-title":"Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)","volume":"21","author":"Chen","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.008_bib171","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S2213-2600(21)00405-7","article-title":"The course of action for effective anti-cytokine treatment in COVID-19","volume":"9","author":"Cavalli","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.008_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.154","article-title":"Inflammatory pathways in COVID-19: mechanism and therapeutic interventions","volume":"3","author":"Jiang","year":"2022","journal-title":"MedComm"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012500142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012500142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:21:04Z","timestamp":1781234464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961012500142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":172,"alternative-id":["S135961012500142X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.10.008","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 innate immune recognition and implications for respiratory health","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}